Next Article in Journal
Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein–Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation
Next Article in Special Issue
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
Previous Article in Journal
The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design
 
 
Review

Article Versions Notes

Vaccines 2020, 8(4), 776; https://doi.org/10.3390/vaccines8040776
Action Date Notes Link
article pdf uploaded. 18 December 2020 15:01 CET Version of Record https://www.mdpi.com/2076-393X/8/4/776/pdf-vor
article pdf uploaded. 18 December 2020 16:59 CET Updated version of record https://www.mdpi.com/2076-393X/8/4/776/pdf-vor
article xml file uploaded 21 December 2020 05:16 CET Original file -
article xml uploaded. 21 December 2020 05:16 CET Update https://www.mdpi.com/2076-393X/8/4/776/xml
article pdf uploaded. 21 December 2020 05:16 CET Updated version of record https://www.mdpi.com/2076-393X/8/4/776/pdf
article html file updated 21 December 2020 05:17 CET Original file -
article html file updated 23 July 2022 05:55 CEST Update https://www.mdpi.com/2076-393X/8/4/776/html
Back to TopTop